Ciubotaru, A.; Smihor, M.I.; Grosu, C.; Alexa, D.; Covali, R.; Anicăi, R.-C.; Păvăleanu, I.; Cucu, A.I.; Bobu, A.M.; Ghiciuc, C.M.;
et al. Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice. Diagnostics 2025, 15, 1178.
https://doi.org/10.3390/diagnostics15091178
AMA Style
Ciubotaru A, Smihor MI, Grosu C, Alexa D, Covali R, Anicăi R-C, Păvăleanu I, Cucu AI, Bobu AM, Ghiciuc CM,
et al. Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice. Diagnostics. 2025; 15(9):1178.
https://doi.org/10.3390/diagnostics15091178
Chicago/Turabian Style
Ciubotaru, Alin, Mădălina Irina Smihor, Cristina Grosu, Daniel Alexa, Roxana Covali, Robert-Constantin Anicăi, Ioana Păvăleanu, Andrei Ionuț Cucu, Amelian Mădălin Bobu, Cristina Mihaela Ghiciuc,
and et al. 2025. "Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice" Diagnostics 15, no. 9: 1178.
https://doi.org/10.3390/diagnostics15091178
APA Style
Ciubotaru, A., Smihor, M. I., Grosu, C., Alexa, D., Covali, R., Anicăi, R.-C., Păvăleanu, I., Cucu, A. I., Bobu, A. M., Ghiciuc, C. M., & Ignat, E. B.
(2025). Neurodegenerative Biomarkers in Multiple Sclerosis: At the Interface Between Research and Clinical Practice. Diagnostics, 15(9), 1178.
https://doi.org/10.3390/diagnostics15091178
